EpigenTek is committed to minimizing our environmental impact and supporting a cleaner, healthier life science industry.
EpigenTek Awarded A Bronze Medal In EcoVadis Assessment
EpigenTek has been awarded a bronze medal from EcoVadis in recognition of its commitment to sustainability and ethics. Outperforming 63 percent of the other companies that applied for this assessment, EpigenTek is also rated in the top 23% of the life sciences industry.
EcoVadis is a ratings platform that audits and evaluates more than 75,000 companies on their environmental performance based on 21 indicators divided into four categories: environment, labor and human rights, ethics, and sustainable procurement. The areas of particular focus are Environment, Labor/Human Rights, and Ethics.
Specific strengths highlighted by EcoVadis include:
Initiatives to reduce office waste, including paper, cardboard, cartridges, and computer parts
Encouragement of on-site recycling through proper office waste disposal
Exemplary policy of comprehensive health care coverage of employees
Regular annual assessment of individual performance
Training of relevant employees and comprehensive documentation on health and safety risks
Standardized policies on information security
Standardized policies on conflicts of interest, whistleblowing, and corruption issues
Digital Datasheets
EpigenTek is reducing our environmental footprint by eliminating unnecessary printing. Most customers refer to and print user guides or datasheets from product pages in advance, and returning customers often do not need the same printed information repeatedly.
This initiative helps expedite logistics during order fulfillment while reducing ink and paper waste. Digital datasheets are easily accessible online.
EpigenTek takes its responsibility to ethically produce antibodies seriously and expects its contract manufacturers and suppliers to adhere to humane treatment and proper welfare of animals during the production process.
Least invasive inoculation process with appropriate aseptic technique and minimal injection volume
Regular monitoring of injection sites for potential inflammation or lesions
Preference for non-Freund's Adjuvants unless absolutely necessary, with only one priming dose of Freund's Complete Adjuvant permitted
Provision of regular care, sufficient feeding, and non-crowded habitat with acceptable hygiene to minimize stress and infection risk
Assessment process for animal welfare, pain, and distress levels, with proper euthanization when visible signs are detected
Blood collection preference via ear vein by local anesthesia and needle for rabbits, with terminal anesthesia required for any cardiac puncture
Maximum blood removal should not exceed 10% of total blood volume if collected every two weeks, or 15% if collected every four weeks
Disposition of animals should be conducted by humane euthanasia procedures or, preferably, by re-homing where relevant adoption programs are in place
Cart (0)
